- Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.Sun, Yan; Hu, Chaosu; Lin, Qin; Gao, Li; Wang, Jianhua; Zhu, Xiaodong; Hao, Junfang; Lang, Jin Yi; Wang, Peiguo; Ye, Ming; Li, Xia; Xu, Benhua; Wu, Rong; Bai, Chunmei; You, Qingshan; Chen, Xiaozhong; Wang, Jun; Hu, Desheng; Wu, Gang; Pan, Jian-JiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 4
- Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter studyWang, J.; Jiang, P.; Wei, L.; Zou, L.; Li, X.; Wang, C.; Sun, X.; Ding, L.; Yuan, X.; Cheng, H.; Wu, D.; Cai, R.; Yin, R.; Zhang, J.; Qiu, H.; Wang, T.; Gao, K.; Zhuo, Y.; Zhang, Y.; Zhao, F.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic CancerQin, Shukui*; Li, Jin; Bai, Yuxian; Wang, Zishu; Chen, Zhendong; Xu, Ruihua; Xu, Jianming; Zhang, Hongmei; Chen, Jia; Yuan, Ying; Liu, Tianshu; Yang, Lin; Zhong, Haijun; Chen, Donghui; Shen, Lin; Hao, Chunyi; Fu, Deliang; Cheng, Ying; Yang, Jianwei; Wang, Qiong; Qin, Baoli; Pan, Hongming; Zhang, Jun; Bai, Xianhong; Zheng, QingshanJournal of Clinical Oncology, 2023, 41(33): 5163-+.被引 1
会议论文
Nimotuzumab combined with gemcitabine versus gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer: A prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial.
12被引6阅读
